DLL3 and neoplasm: The last group is delta-like protein 3 (DLL-3), a ligand in the Notch signalling pathway that is highly expressed in tumours of neuroendocrine origin, such as neuroendocrine carcinomas (NEC) or neuroendocrine tumours (NET), which are related to cell cycle development and death signaling.